Insider trading

Period: 120 months Stock: ARWR Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

136 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

136 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

136 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

136 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
136 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
136 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

136 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
3 Mar 2023
Sold, plan not stated
$370.58K 11,350 at 32.65
59.1%
Sold half or more
27 Feb 2023
GIVEN DOUGLAS B Director · indirect
Sold, plan not stated
$28.54K 875 at 32.62
6.3%
9 Jan 2023
Sold, plan not stated
$96.00K 3,200 at 30.00
10.0%
5 Jan 2023
O'Brien Patrick COO and General Counsel
Sold, plan not stated 2×
$560.85K 15,000 at 37.39
3.5%
5 Jan 2023
Hamilton James C Chief Discovery/Trans Medicine
Sold, plan not stated 2×
$516.23K 13,803 at 37.40
6.7%
3 Jan 2023
O'Brien Patrick COO and General Counsel
Sold, plan not stated 8×
$670.80K 17,500 at 38.33
4.6%
3 Jan 2023
Hamilton James C Chief Discovery/Trans Medicine
Sold, plan not stated 8×
$396.74K 10,338 at 38.38
6.6%
29 Dec 2022
Myszkowski Kenneth Allen Chief Financial Officer
Sold, plan not stated
$1.23M 30,625 at 40.00
8.3%
21 Nov 2022
San Martin Javier Chief Medical Officer
Sold, plan not stated 2×
$584.74K 19,500 at 29.99
17.6%
11 Feb 2022
Anzalone Christopher Richard Chief Executive Officer
Sold, plan not stated 4×
$7.60M 146,388 at 51.91
3.5%
5 Jan 2022
Myszkowski Kenneth Allen Chief Financial Officer
Sold, plan not stated 4×
$2.47M 40,000 at 61.70
7.9%
5 Jan 2022
O'Brien Patrick General Counsel
Sold, plan not stated 5×
$2.01M 32,500 at 61.72
8.5%
5 Jan 2022
Hamilton James C Senior Vice President
Sold, plan not stated 5×
$385.77K 6,250 at 61.72
3.9%
4 Jan 2022
Hamilton James C Senior Vice President
Sold, plan not stated 5×
$1.27M 19,375 at 65.49
10.7%
3 Jan 2022
Sold, plan not stated 3×
$291.24K 4,500 at 64.72
14.9%
3 Jan 2022
PERRY MICHAEL S Director
Sold, plan not stated 3×
$291.19K 4,500 at 64.71
5.0%
3 Jan 2022
Sold, plan not stated 3×
$291.18K 4,500 at 64.71
20.9%
3 Jan 2022
Sold, plan not stated 3×
$262.23K 4,050 at 64.75
45.0%
28 Dec 2021
Ferrari Mauro Director
Sold, plan not stated
$227.19K 3,400 at 66.82
8.5%
28 Dec 2021
GIVEN DOUGLAS B Director
Bought
$43.47K 655 at 66.37
0.6%
First buy on file
15 Dec 2021
Anzalone Christopher Richard Chief Executive Officer
Sold, plan not stated 5×
$4.05M 60,000 at 67.56
1.8%
19 Nov 2021
San Martin Javier Chief Medical Officer
Sold, plan not stated 3×
$1.35M 19,500 at 69.31
14.9%
22 Oct 2021
Anzalone Christopher Richard Chief Executive Officer
Sold, plan not stated 2×
$3.28M 50,000 at 65.63
1.5%
20 Oct 2021
Anzalone Christopher Richard Chief Executive Officer
Sold, plan not stated
$993.45K 15,000 at 66.23
0.4%
13 Sep 2021
Sold, plan not stated 2×
$318.80K 5,000 at 63.76
35.7%
9 Sep 2021
GIVEN DOUGLAS B Director
Sold, plan not stated
$326.20K 5,000 at 65.24
4.4%
24 Jun 2021
Sold, plan not stated
$449.25K 5,000 at 89.85
18.9%
22 Jun 2021
GIVEN DOUGLAS B Director
Sold, plan not stated
$401.45K 4,500 at 89.21
3.8%
22 Jun 2021
Hassard James Chief Commercial Officer
Sold, plan not stated
$323.42K 3,625 at 89.22
3.3%
22 Feb 2021
GIVEN DOUGLAS B Director · indirect
Sold, plan not stated
$99.82K 1,125 at 88.73
7.5%
8 Feb 2021
O'Brien Patrick General Counsel
Sold, plan not stated 4×
$7.96M 90,000 at 88.46
23.5%
15 Jan 2021
GIVEN DOUGLAS B Director · indirect
Sold, plan not stated
$249.84K 3,000 at 83.28
19.4%
14 Jan 2021
Hamilton James C Senior Vice President
Sold, plan not stated 2×
$812.94K 10,000 at 81.29
7.3%
12 Jan 2021
Myszkowski Kenneth Allen Chief Financial Officer
Sold, plan not stated
$116.72K 1,441 at 81.00
0.3%
11 Jan 2021
Myszkowski Kenneth Allen Chief Financial Officer
Sold, plan not stated
$939.59K 11,597 at 81.02
2.5%
7 Jan 2021
Hassard James Chief Commercial Officer
Sold, plan not stated
$1.17M 15,625 at 75.00
12.5%
6 Jan 2021
Myszkowski Kenneth Allen Chief Financial Officer
Sold, plan not stated 3×
$2.22M 30,625 at 72.44
6.3%
6 Jan 2021
O'Brien Patrick General Counsel
Sold, plan not stated 3×
$1.81M 25,000 at 72.41
7.9%
6 Jan 2021
Hamilton James C Senior Vice President
Sold, plan not stated 3×
$1.40M 19,375 at 72.48
12.4%
5 Jan 2021
Hamilton James C Senior Vice President
Sold, plan not stated 4×
$1.41M 19,375 at 72.53
11.1%
4 Jan 2021
PERRY MICHAEL S Director
Sold, plan not stated
$304.36K 4,000 at 76.09
4.3%
4 Jan 2021
GIVEN DOUGLAS B Director
Sold, plan not stated
$304.32K 4,000 at 76.08
3.2%
4 Jan 2021
Sold, plan not stated
$285.30K 3,750 at 76.08
11.0%
17 Dec 2020
GIVEN DOUGLAS B Director
Sold, plan not stated
$719.65K 9,075 at 79.30
7.3%
17 Dec 2020
GIVEN DOUGLAS B Director · indirect
Sold, plan not stated
$39.80K 500 at 79.59
3.2%
10 Dec 2020
Sold, plan not stated 2×
$213.78K 3,000 at 71.26
10.7%
9 Dec 2020
Anzalone Christopher Richard Chief Executive Officer
Sold, plan not stated 4×
$2.67M 38,676 at 69.06
1.5%
8 Dec 2020
Anzalone Christopher Richard Chief Executive Officer
Sold, plan not stated
$1.11M 16,324 at 67.97
0.6%
20 Nov 2020
Bradshaw Curt Chief Scientific Officer
Sold, plan not stated
$1.07M 15,625 at 68.73
100%
Sold half or more
19 Nov 2020
San Martin Javier Chief Medical Officer
Sold, plan not stated
$1.35M 19,500 at 69.39
13.0%
Showing 1–50 of 136. Page 1 of 3 Older →